NO20062384L - Anvendelse av BH4 for bahandling av respiratoriske sykdommer - Google Patents

Anvendelse av BH4 for bahandling av respiratoriske sykdommer

Info

Publication number
NO20062384L
NO20062384L NO20062384A NO20062384A NO20062384L NO 20062384 L NO20062384 L NO 20062384L NO 20062384 A NO20062384 A NO 20062384A NO 20062384 A NO20062384 A NO 20062384A NO 20062384 L NO20062384 L NO 20062384L
Authority
NO
Norway
Prior art keywords
treatment
respiratory diseases
derivatives
tetiahydrobiopterin
copd
Prior art date
Application number
NO20062384A
Other languages
English (en)
Inventor
Christian Schudt
Wolf-Ruediger Ulrich
Christian Hesslinger
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of NO20062384L publication Critical patent/NO20062384L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Otolaryngology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Oppfinnelsen beskriver anvendelsen av tetiahydrobiopterin (BH4) eller derivater derav for behandlingen av KOL. I en foretrukket utførelsesform kombineres BH4 eller derivater derav med arginin eller derivater derav.
NO20062384A 2003-10-31 2006-05-24 Anvendelse av BH4 for bahandling av respiratoriske sykdommer NO20062384L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03024844 2003-10-31
PCT/EP2004/052725 WO2005041975A1 (en) 2003-10-31 2004-10-29 Use of bh4 for the treatment of respiratory diseases

Publications (1)

Publication Number Publication Date
NO20062384L true NO20062384L (no) 2006-05-24

Family

ID=34530659

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062384A NO20062384L (no) 2003-10-31 2006-05-24 Anvendelse av BH4 for bahandling av respiratoriske sykdommer

Country Status (13)

Country Link
US (1) US20070049599A1 (no)
EP (1) EP1682148A1 (no)
JP (1) JP2007509909A (no)
KR (1) KR20060120147A (no)
CN (1) CN1871011A (no)
AU (1) AU2004285300A1 (no)
BR (1) BRPI0416105A (no)
CA (1) CA2543252A1 (no)
IL (1) IL174589A0 (no)
MX (1) MXPA06004687A (no)
NO (1) NO20062384L (no)
WO (1) WO2005041975A1 (no)
ZA (1) ZA200602536B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006120176A2 (en) * 2005-05-11 2006-11-16 Nycomed Gmbh Combination of the pde4 inhibitor roflumilast and a tetrahydrobiopterin derivative
CN103988080B (zh) * 2011-10-11 2016-06-08 加利福尼亚大学董事会 用于腹主动脉瘤的生物标记物
EP3548497A4 (en) 2016-11-29 2020-09-02 Censa Pharmaceuticals Inc. SEPIAPTERIN POLYMORPHS AND THEIR SALTS
CN110312721A (zh) 2016-11-29 2019-10-08 显莎制药公司 墨蝶呤的多晶型物
EP3675863A4 (en) 2017-09-01 2021-01-27 PTC Therapeutics MP, Inc. PHARMACEUTICAL COMPOSITIONS WITH SEPIAPTERIN AND USES THEREOF
US20240115573A1 (en) * 2021-03-26 2024-04-11 Emory University Managing the Acute and Long-Term Effects of Coronaviral Infections and Compositions Related Thereto

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877176A (en) * 1991-12-26 1999-03-02 Cornell Research Foundation, Inc. Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
US5830461A (en) * 1992-11-25 1998-11-03 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods for promoting wound healing and treating transplant-associated vasculopathy
DE4418097A1 (de) * 1994-05-24 1995-11-30 Cassella Ag Verwendung von Tetrahydropteridin-Derivaten als Hemmstoffe der NO-Synthase
AU2896695A (en) * 1994-07-14 1996-02-16 Glaxo Wellcome House Nitric oxide synthase inhibitors for inhibiting the production of airway mucus
WO1998008516A1 (en) * 1996-08-30 1998-03-05 Suntory Limited Preventives or remedies for diseases induced by hypofunction of nitric oxide synthase (nos)
SE0000307D0 (sv) * 2000-01-31 2000-01-31 Univ Zuerich Method and formulation för treatment of vasoconstriction
US6544994B2 (en) * 2000-06-07 2003-04-08 Eprov Ag Pharmaceutical preparation for treating or preventing cardiovascular or neurological disorders by modulating of the activity of nitric oxide synthase
US20040087653A1 (en) * 2002-05-16 2004-05-06 Manning Pamela T. Methods for the treatment of respiratory diseases and conditions with a selective iNOS inhibitor and a PDE inhibitor and compositions therefor
US20040097467A1 (en) * 2002-08-22 2004-05-20 Vijaya Juturu Arginine silicate inositol complex and use thereof

Also Published As

Publication number Publication date
CN1871011A (zh) 2006-11-29
EP1682148A1 (en) 2006-07-26
US20070049599A1 (en) 2007-03-01
AU2004285300A1 (en) 2005-05-12
IL174589A0 (en) 2006-08-20
ZA200602536B (en) 2007-06-27
BRPI0416105A (pt) 2007-01-02
MXPA06004687A (es) 2006-06-27
KR20060120147A (ko) 2006-11-24
JP2007509909A (ja) 2007-04-19
CA2543252A1 (en) 2005-05-12
WO2005041975A1 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
IS2994B (is) Fosfónöt, monofosfónamidöt, bisfosfónamidöt til meðhöndlunar á veirusjúkdómum
ATE408601T1 (de) Fredericamycin-derivate
NL300933I2 (nl) Letermovir
IS7814A (is) Fenetanólamín afleiða í meðhöndlun á öndunarfærasjúkdómum.
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
NO20091413L (no) WNT-antagonister og deres anvendelse i diagnostiseringen og behandlingen av WNT-medierte forstyrrelser
DK1656346T3 (da) 1,2,3,4-tetrasubstituerede indol til behandling af luftvejssygdomme
ECSP045191A (es) "nuevos péptidos como inhibidores de la proteasa serina ns3 del virus de la hepatitis c"
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
CY1109568T1 (el) Ενωσεις βενζο(d)ισοξαζολ-3-υλαμινης και η χρησιμοποιηση τους σαν προσδεματα υποδοχεα βανιλλοειδων
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
CY1110780T1 (el) Τοπικα σκευασματα νεπαφενακης
SE0301653D0 (sv) Novel compounds
UA85559C2 (en) Aminobenzophenone compounds
UY30846A1 (es) Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
BRPI0511396A (pt) derivados de retinal e métodos para uso no tratamento de enfermidades visuais
ATE448232T1 (de) Substituierte heterozyklen
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
EA200700717A1 (ru) Сульфонамиды
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
ES1053382Y (es) Protesis dilatadora del vestibulo nasal.
ES2570332T3 (es) La combinación de anticolinérgicos y antagonistas del receptor de leucotrieno para el tratamiento de enfermedades respiratorias
NO20065115L (no) Cellulaer tillatende faktor for virus, og anvendelse derav
ECSP10010379A (es) Derivados de oxindol sustituido y su uso para el tratamiento de enfermedades dependientes de la vasopresina
NO20055098D0 (no) Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

FC2A Withdrawal, rejection or dismissal of laid open patent application